News from cardiome pharma corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 29, 2015, 12:00 ET

SteadyMed and Cardiome Enter into a License Agreement for the Commercialization Rights to Trevyent® Outside the U.S.

SAN RAMON, CA and VANCOUVER, June 29, 2015 /PRNewswire/ - SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on...

Jun 24, 2015, 08:30 ET

Cardiome Pharma Corp. Announces Voting Results

NASDAQ: CRME   TSX: COM VANCOUVER, June 24, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the...

Jun 16, 2015, 08:30 ET

Cardiome to Present at JMP Securities Healthcare Conference

NASDAQ: CRME   TSX: COM VANCOUVER, June 16, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced...

Jun 12, 2015, 08:30 ET

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

NASDAQ: CRME     TSX: COM VANCOUVER, June 12, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today...

Jun 03, 2015, 13:00 ET

Cardiome Appoints David Dean Vice President, Business Development and Investor Relations

NASDAQ: CRME   TSX: COM VANCOUVER, June 3, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) is pleased to...

May 13, 2015, 11:10 ET

Cardiome und AOP Orphan Pharma treffen Vereinbarung zur Vermarktung von ESMOCARD

Die Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) gab heute bekannt, dass sich das Unternehmen mit AOP Orphan Pharma ("AOP") darauf...

May 13, 2015, 07:00 ET

Cardiome Reports First Quarter 2015 Financial Results

Cardiome to conduct conference call and webcast today, May 13, 2015 at 8:00 a.m. Eastern (5:00 a.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER, May...

May 12, 2015, 14:55 ET

Cardiome et AOP Orphan Pharma concluent un accord en vue de la commercialisation d'ESMOCARD

Cardiome Pharma Corp. (NASDAQ : CRME / TSX : COM) a annoncé aujourd'hui avoir conclu un accord avec AOP Orphan Pharma (« AOP ») en...

May 12, 2015, 13:19 ET

Cardiome y AOP Orphan Pharma firman un acuerdo de comercialización para ESMOCARD

Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ha anunciado hoy que la compañía ha entrado en un acuerdo de comercialización con...

May 12, 2015, 08:30 ET

Cardiome and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreement

NASDAQ: CRME   TSX: COM VANCOUVER, May 12, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that the...

May 07, 2015, 17:30 ET

Cardiome To Hold First Quarter 2015 Financial Results Conference Call On May 13

VANCOUVER, May 7, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report financial results for the...

Apr 27, 2015, 16:00 ET

Cardiome to Present at Bloom Burton & Co. Healthcare Investor Conference

NASDAQ: CRME TSX: COM VANCOUVER, April 27, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Jennifer...

Apr 09, 2015, 11:00 ET

Cariome erhält BRINAVESS-Erstattungsgenehmigung von den belgischen Behörden

NASDAQ: CRME TSX: COM   Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) gab heute die Genehmigung für BRINAVESS™ zur...

Apr 09, 2015, 09:42 ET

Le remboursement du BRINAVESS de Cardiome autorisé par les autorités belges

NASDAQ : CRME TSX : COM   Cardiome Pharma Corp. (NASDAQ : CRME / TSX : COM) a annoncé aujourd'hui que le régime national...

Apr 09, 2015, 08:30 ET

Cardiome Receives BRINAVESS Reimbursement Approval From Belgian Authorities

NASDAQ: CRME   TSX: COM VANCOUVER, April 9, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the...

Apr 09, 2015, 08:30 ET

Cardiome recibe la aprobación de reembolso BRINAVESS de las autoridades belgas

NASDAQ: CRME TSX: COM   Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) anunció hoy la aprobación de BRINAVESS™ para su...

Mar 12, 2015, 07:00 ET

Cardiome reports fourth quarter and full year 2014 financial results

- Cardiome to conduct conference call and webcast today, March 12, at 8:00 a.m. Eastern (5:00 a.m. Pacific) NASDAQ: CRME TSX: COM VANCOUVER,...

Mar 05, 2015, 13:00 ET

Cardiome to Hold Fourth Quarter and Full Year 2014 Financial Results Conference Call on March 12

NASDAQ: CRME TSX: COM VANCOUVER, March 5, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report...

Dec 19, 2014, 08:00 ET

Cardiome Enters Development and Commercialization Agreement with Eddingpharm for BRINAVESS™ in China

NASDAQ: CRME TSX: COM VANCOUVER, Dec 19, 2014 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that one of its...

Nov 18, 2014, 05:13 ET

Cardiome schließt Vermarktungsvereinbarung mit Aspen zwecks Vertrieb von BRINAVESS® in Südafrika

Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) gab heute bekannt, dass eine Tochtergesellschaft des Unternehmens eine Vereinbarung mit Pharmacare...